Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

First in vitro study of P80DOX-NP completed

Aug. 12, 2002

Targeted Genetics restructures

Aug. 12, 2002

Biomed-101 phase Ib enrollment completed

Aug. 12, 2002

Initial phase I results for Large Scale Biology's personalized NHL vaccines

Aug. 12, 2002

ProlX receives SBIR grant to advance HIF inhibitor cancer therapy

Aug. 12, 2002

The CXCR4-CXCL12/SDF-1 pathway is a possible target for non-Hodgkin's lymphoma therapy

Aug. 12, 2002

Novel HDAC inhibitors identified at Beacon

Aug. 9, 2002

Pivotal phase III trial of RSR-13 completes enrollment

Aug. 9, 2002

Little or no activity for KW-2189 in advanced malignant melanoma

Aug. 9, 2002

Servier researchers identify new metalloproteinase inhibitors

Aug. 8, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...